Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | June 17, 2020 | News story | Research and Development |Â Â COVID-19, coronavirus, coronavirus roundupÂ
There is a fear of a second wave of coronavirus coming out of China, as the country reported its highest amount of cases in months as a new outbreak has been linked to a food market in Beijing. In terms of breakthrough in treatments, A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%.
In COVID-19 vaccine news, Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, while Beijing-based firm Sinovac has revealed new Phase 1/2 data on its own COVID-19 vaccine, known as CoronaVac.
1. US trial of ivermectin cuts coronavirus mortality by 40% – Published 10/06/20
A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%.
2. Sinovac’s COVID-19 vaccine successfully generates immune response at Phase ½ – Published 16/06/20
As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm Sinovac has revealed new Phase 1/2 data on its own COVID-19 vaccine, known as CoronaVac.
3. Fear of a coronavirus second wave as China reports highest number of cases in months – Published 15/06/20
China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food market in Beijing.
4. Eli Lilly’s coronavirus antibody treatments could be available by September – Published 11/06/20
An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its chief scientists.
5. Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July – Published 12/06/2020
Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials.
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
